eVeDrug
Created in 2013
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,992 626Activities
Technologies
Entity types
Location
6 Rue du Maréchal Leclerc, 91270 Vigneux-sur-Seine, France
Vigneux-sur-Seine
France
Employees
Scale: 2-10
Estimated: 6
Engaged corporates
18
2 10Added in Motherbase
6 years, 1 month ago
biotech Value proposition
[Automatic translation follows] eVeDrug calls upon various stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and who draw on their experience acquired both from industrial circles (laboratories and manufacturers) and institutional circles (health authorities from different countries).
Above all, eVeDrug wishes to restore trust between patients and their health system by placing the main person concerned (the patient himself) at the center of the health system responsible for protecting him.
Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) who has taken a medicine or any other health product, and who has an adverse effect likely to be due to this medicine or this other health product, to report it directly from their Smartphone or any other mobile terminal (tablet, etc.).
My eReport includes all the minimum information necessary for the transmission of a case: a reporter; a patient; a drug and the description of the adverse effect.
Your report will be sent as a priority to the pharmaceutical laboratory concerned, if it is subscribed to eVeDrug.
Failing this, your report will be sent to the National Agency of the country in which the adverse effect occurred. In France, your report will be sent to one of the Regional Pharmacovigilance Centers dependent on the National Agency for the Safety of Medicines and Health Products (ANSM).
In order to keep track of your report and be able to consult it at any time, a copy of your report is kept on your Smartphone (or on your tablet ...).
eVeDrug also distributes My eClinical intended for any investigator wishing to report an SAE to the sponsor directly from their Smartphone (or any other digital medium).
Post Market Reports: My eReport, Pre Market Reports: My eClinical, Monitoring of sensitive drugs (inverted black triangle), and Monitoring of PASS / PAES studiesOriginal language
eVeDrug fait appel à différents intervenants tous liés au domaine de la Pharmacovigilance : des professionnels de l'industrie pharmaceutiques et des scientifiques ayant mis leur savoir faire en commun, et forts de leur expérience acquise aussi bien auprès des milieux Industriels (les laboratoires et les fabricants) que des milieux Institutionnels (les autorités de santé de différents pays).
eVeDrug souhaite avant tout restaurer la confiance entre les patients et leur système de santé en plaçant le principal intéressé (le patient lui-même) au centre du système de santé chargé le protéger.
Ainsi, eVeDrug distribue l'application gratuite My eReport qui permet à toute personne (patient, proche, professionnel de santé ...) qui a pris un médicament ou tout autre produit de santé, et présentant un effet indésirable susceptible d'être dû à ce médicament ou à cet autre produit de santé, de le déclarer directement à partir de son Smartphone ou de tout autre terminal mobile (tablette...).
My eReport comprend toutes les informations minimales nécessaires à la transmission d'un cas : un déclarant ; un patient ; un médicament et la description de l'effet indésirable.
Votre déclaration sera transmise en priorité au laboratoire pharmaceutique concerné, si celui-ci est abonné à eVeDrug.
A défaut, votre déclaration sera transmise à l'Agence Nationale du pays dans lequel l'effet indésirable est survenu. En France, votre déclaration sera transmise à l'un des Centres Régionaux de Pharmacovigilance dépendant de l'Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM).
Afin de garder trace de votre déclaration et de pouvoir la consulter à tout moment, un double de votre déclaration est conservé sur votre Smartphone (ou sur votre tablette ...).
eVeDrug distribue également My eClinical destinée à tout investigateur souhaitant déclarer au promoteur un EIG directement depuis son Smartphone (ou tout autre support numérique).
Déclarations Post Market : My eReport, Déclarations Pré Market : My eClinical, Suivi de médicaments sensibles (triangle noir inversé), and Suivi des études PASS / PAES
eVeDrug - Solutions of health vigilances and e-health
https://www.evedrug.eu/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Other 31 Mar 2023 | | |
 Orange Telecoms, Law Practice, Telecommunications | Orange Telecoms, Law Practice, Telecommunications | Other 17 Dec 2020 | | |
 Inria Research, Research Services | Inria Research, Research Services | Other 26 Sep 2017 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 30 Jan 2021 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 23 Mar 2016 | | |
 Huawei Electricals, Telecommunications | Huawei Electricals, Telecommunications | Other 6 Mar 2020 | | |
 Assurance Maladie Insurance, Government Administration | Assurance Maladie Insurance, Government Administration | Other 26 Sep 2016 | | |
 STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Not capitalistic Not partnership Event 9 Oct 2020 | | |
 Pierre Fabre Laboratories Pharmaceutical, Pharmaceutical Manufacturing | Pierre Fabre Laboratories Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Not partnership Event 23 Sep 2021 | | |
 Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Not capitalistic Partnership Event 30 Oct 2019 | | |